Abstract
Short and long sleep durations have been associated with inflammation and chronic diseases. To study the association between sleep duration/quality and HIV disease severity, a cross-sectional study was conducted in patients living with HIV (PLWHs) using self-administered questionnaires assessing total sleep time, insomnia (ICSD-3 criteria), and poor sleep quality (PSQI > 5). Multivariable logistic regression identified the factors associated with sleep disorders and with HIV features. 640 Parisian ambulatory PLWHs were included. The prevalence of insomnia was 50 and 68% of patients had a PSQI > 5. Patients with CD4 count < 500 cells/mm3 were more likely to be long sleepers (> 8 h/day) (OR 1.49; 95% CI [1.10–1.99]: p < 0.01), and less likely to be short sleepers (< 6 h/day) (OR 0.69; 95% CI[0.50–0.96]; p = 0.04) or to experience insomnia (OR 0.59; 95% CI[0.40–0.86]; p < 0.01). HIV features were not associated with a PSQI > 5. Thus, insomnia and impaired sleep quality were highly prevalent in well-controlled PLWHs and the severity of HIV infection was associated with long sleep times.
Similar content being viewed by others
References
Girardin J-L, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, et al. Insomnia symptoms and HIV infection among participants in the Women’s Interagency HIV Study. Sleep. 2012;35:131–7.
Crum-Cianflone NF, Roediger MP, Moore DJ, Hale B, Weintrob A, Ganesan A, et al. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;54:1485–94.
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥ 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41:433–45.
Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55:600–7.
Krueger JM, Clinton JM, Winters BD, Zielinski MR, Taishi P, Jewett KA, et al. Involvement of cytokines in slow wave sleep. Prog Brain Res. 2011;193:39–47.
Allavena C, Guimard T, Billaud E, De la Tullaye S, Reliquet V, Pineau S, et al. Prevalence and risk factors of sleep disturbance in a large hiv-infected adult population. AIDS Behav. 2016;20:339–44.
Siegel JM. Clues to the functions of mammalian sleep. Nature. 2005;437:1264–71.
Lange T, Dimitrov S, Born J. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci. 2010;1193:48–59.
Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev. 2012;16:137–49.
Faraut B, Boudjeltia KZ, Dyzma M, Rousseau A, David E, Stenuit P, et al. Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction. Brain Behav Immun. 2011;25:16–24.
Born J, Lange T, Hansen K, Mölle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol Baltim Md. 1950;1997(158):4454–64.
Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414–20.
Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484–92.
Léger D, Beck F, Richard J-B, Sauvet F, Faraut B. The risks of sleeping “too much”. Survey of a national representative sample of 24671 adults (INPES health barometer). PLoS ONE. 2014;9:e106950.
Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2015;80:40–52.
Faraut B, Touchette E, Gamble H, Royant-Parola S, Safar ME, Varsat B, et al. Short sleep duration and increased risk of hypertension: a primary care medicine investigation. J Hypertens. 2012;30:1354–63.
Bayon V, Leger D, Gomez-Merino D, Vecchierini M-F, Chennaoui M. Sleep debt and obesity. Ann Med. 2014;46:264–72.
Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10:329–36.
Thase ME. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci. 2006;8:217–26.
Dray-Spira R. Health status of peopole living with IV followed at hospital in metropolitan France in 2011 and characteristics of those recently diagnosed. Results of the ANRS-VESPA2 Study. BEH N°26-27. INVS; 2013.
Wibbeler T, Reichelt D, Husstedt I-W, Evers S. Sleepiness and sleep quality in patients with HIV infection. J Psychosom Res. 2012;72:439–42.
Gamaldo CE, Spira AP, Hock RS, Salas RE, McArthur JC, David PM, et al. Sleep, function and HIV: a multi-method assessment. AIDS Behav. 2013;17:2808–15.
Léger D, du Roscoat E, Bayon V, Guignard R, Pâquereau J, Beck F. Short sleep in young adults: insomnia or sleep debt? Prevalence and clinical description of short sleep in a representative sample of 1004 young adults from France. Sleep Med. 2011;12:454–62.
American Academy of Sleep Medicine. International classification of sleep disorders. Diagnostic and coding manual, 3rd ed. American Academy of Sleep Medicine, Darien, IL; 2014.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485–91.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
Blais FC, Gendron L, Mimeault V. Morin CM [evaluation of insomnia: validity of 3 questionnaires]. L’Encephale. 1997;23:447–53.
Collet L. The shortened Beck depression inventory (13 items). Study of the concurrent validity with the Hamilton scale and Widlöcher’s retardation scale. Cottraux J L’Encéphale. 1986;12:77–9.
Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171–8.
Duracinsky M, Lalanne C, Le Coeur S, Herrmann S, Berzins B, Armstrong AR, et al. Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease. J Acquir Immune Defic Syndr. 1999;2012(59):506–15.
CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm. Accessed 27 Dec 2016.
Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714692/. Accessed 19 Jun 2015.
Institut National du Sommeil et de la Vigilance, MGEN. Enquête Sommeil et transports. 14ème journéee du sommeil; 2014. www.institut-sommeil-vigilance.org/wp-content/uploads/2014/07/resultats_enquete_mgen2014.pdf. Accessed 27 Jul 2015.
Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, et al. Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys). AIDS Care. 2014;26(Suppl 1):S29–40.
Harel O, Perkins N, Schisterman EF. The use of multiple imputation for data subject to limits of detection. Sri Lankan J Appl Stat. 2014;5:227–46.
Natale V, Léger D, Martoni M, Bayon V, Erbacci A. The role of actigraphy in the assessment of primary insomnia: a retrospective study. Sleep Med. 2014;15:111–5.
Zeidan J. Les différentes mesures du bien-être subjectif, the various approaches to the measurement of subjective well-being. Rev Fr Décon. 2013;27:35–70.
Miller D, Steele Gray C, Kuluski K, Cott C. Patient-centered care and patient-reported measures: let’s look before we leap. The Patient. 2015;8:293–9.
Wu J, Wu H, Lu C, Guo L, Li P. Self-reported sleep disturbances in HIV-infected people: a meta-analysis of prevalence and moderators. Sleep Med. 2015;16:901–7.
Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol Off Publ Int Retrovirol Assoc. 1998;19:260–5.
Cruess DG, Antoni MH, Gonzalez J, Fletcher MA, Klimas N, Duran R, et al. Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. J Psychosom Res. 2003;54:185–9.
Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, et al. Types of sleep problems in adults living with HIV/AIDS. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2012;8:67–75.
Seay JS, McIntosh R, Fekete EM, Fletcher MA, Kumar M, Schneiderman N, et al. Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV. Psychoneuroendocrinology. 2013;38:2647–53.
Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional clusters of CD4+ T cell dysfunction are primarily associated with the CD4/CD8 ratio in chronic HIV infection. PLoS ONE. 2015;10:e0137635.
Mantua J, Spencer RMC. The interactive effects of nocturnal sleep and daytime naps in relation to serum C-reactive protein. Sleep Med. 2015;16:1213–6.
Riemann D, Spiegelhalder K, Espie C, Pollmächer T, Léger D, Bassetti C, et al. Chronic insomnia: clinical and research challenges—an agenda. Pharmacopsychiatry. 2011;44:1–14.
Moeller AA, Wiegand M, Oechsner M, Krieg JC, Holsboer F, Emminger C. Effects of zidovudine on EEG sleep in HIV-infected men. J Acquir Immune Defic Syndr. 1992;5:636–7.
Clifford DB, Evans S, Yang Y, Acosta EP, Ribaudo H, Gulick RM. Long-term Impact of Efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clin Trials. 2009;10:343–55.
Omonuwa TS, Goforth HW, Preud’homme X, Krystal AD. The pharmacologic management of insomnia in patients with HIV. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2009;5:251–62.
Cunnington D, Junge M. Chronic insomnia: diagnosis and non-pharmacological management. BMJ. 2016;355:i5819.
Smith MT, Huang MI, Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev. 2005;25:559–92.
Acknowledgements
The authors wish to thank: all the patients, Sandra Colas, Agnès Cros, Aline Maignan, Christophe Lalanne, Dr Hafeda Rostane, and Pr Jean-Marc Tréluyer for data management and study organization, Dr Jacques Gilquin, Dr Blanca Hadacek, Dr Christophe Kokougan, Dr Audrey Merlet, Dr Lella Nait-Ighil, Dr Thu-Huyen Nguyen, and Pr Alain Sobel, for patient recruitment, and the residents of the Immuno-infectiology Unit.
Funding
This study was funded by the Agence publique française de recherches sur le sida et les hépatites virales (ANRS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors have no conflict of interest in relation with this study.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee “CPP Ile-de-France 1” and with the 1964 Helsinki declaration and its later amendments.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Faraut, B., Malmartel, A., Ghosn, J. et al. Sleep Disturbance and Total Sleep Time in Persons Living with HIV: A Cross-Sectional Study. AIDS Behav 22, 2877–2887 (2018). https://doi.org/10.1007/s10461-018-2179-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-018-2179-1